1-5 of 5
Hui Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P088: Combined inhibition of histone deacetylases and EZH2 for the treatment of Wilms tumors

Hongbing Liu, Nhi Ngo, Chao-Hui Chen, Samir S. El-Dahr
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P088.
https://doi.org/10.1158/1535-7163.TARG-21-P088
Published: 01 December 2021
View article titled, Abstract P088: Combined inhibition of histone deacetylases and EZH2 for the treatment of Wilms tumors
Journal Articles

The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors

Xinyi Wang, Jing Ai, Hongyan Liu, Xia Peng, Hui Chen, Yi Chen, Yi Su, Aijun Shen, Xun Huang, Jian Ding, Meiyu Geng
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (3): 667–679.
https://doi.org/10.1158/1535-7163.MCT-18-0179
Published: 01 March 2019
View article titled, The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors
Open the PDF for The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors in another window
Includes: Supplementary data
Journal Articles

Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy

Hui Chen, Rajyalakshmi Luthra, Mark J. Routbort, Keyur P. Patel, Maria E. Cabanillas, Russell R. Broaddus, Michelle D. Williams
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (7): 1575–1584.
https://doi.org/10.1158/1535-7163.MCT-17-0871
Published: 01 July 2018
View article titled, Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy
Open the PDF for Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy in another window
Includes: Supplementary data
Journal Articles

RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break–Inducing Anticancer Drugs

Hong-Yi Chang, Ting-Chia Chang, Wen-Ya Huang, Chung-Ta Lee, Chia-Jui Yen, Yuh-Shyan Tsai, Tzong-Shin Tzai, Shu-Hui Chen, Nan-Haw Chow
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (2): 276–286.
https://doi.org/10.1158/1535-7163.MCT-15-0311
Published: 07 February 2016
View article titled, RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break–Inducing Anticancer Drugs
Open the PDF for RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break–Inducing Anticancer Drugs in another window
Includes: Supplementary data
Journal Articles

Abstract A83: 4-Ketopinoresinol, a novel naturally occurring ARE activator, induces the Nrf2/HO-1 axis and protects against oxidative stress-induced cell injury via activation of PI3K/AKT signaling.

Ching-Chuan Kuo, Huang-Hui Chen, Yu-Tsen Chen, Yen-Wen Huang, Hui-Ju Tsai
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A83.
https://doi.org/10.1158/1535-7163.TARG-11-A83
Published: 12 November 2011
View article titled, Abstract A83: 4-Ketopinoresinol, a novel naturally occurring ARE activator, induces the Nrf2/HO-1 axis and protects against oxidative stress-induced cell injury via activation of PI3K/AKT signaling.